- Home
- BKSY vs TSHA Comparison
BKSY vs TSHA Comparison
Compare BKSY & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- TSHA
- Stock Information
- Founded
- BKSY 2013
- TSHA 2019
- Country
- BKSY United States
- TSHA United States
- Employees
- BKSY N/A
- TSHA N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- BKSY Technology
- TSHA Health Care
- Exchange
- BKSY Nasdaq
- TSHA Nasdaq
- Market Cap
- BKSY 157.7M
- TSHA 397.8M
- IPO Year
- BKSY N/A
- TSHA 2020
- Fundamental
- Price
- BKSY $11.46
- TSHA $2.10
- Analyst Decision
- BKSY Strong Buy
- TSHA Strong Buy
- Analyst Count
- BKSY 6
- TSHA 8
- Target Price
- BKSY $20.17
- TSHA $6.63
- AVG Volume (30 Days)
- BKSY 673.8K
- TSHA 2.9M
- Earning Date
- BKSY 05-08-2025
- TSHA 05-16-2025
- Dividend Yield
- BKSY N/A
- TSHA N/A
- EPS Growth
- BKSY N/A
- TSHA N/A
- EPS
- BKSY N/A
- TSHA N/A
- Revenue
- BKSY $107,401,000.00
- TSHA $8,333,000.00
- Revenue This Year
- BKSY $32.27
- TSHA N/A
- Revenue Next Year
- BKSY $26.94
- TSHA N/A
- P/E Ratio
- BKSY N/A
- TSHA N/A
- Revenue Growth
- BKSY 7.05
- TSHA N/A
- 52 Week Low
- BKSY $3.86
- TSHA $1.05
- 52 Week High
- BKSY $21.92
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- BKSY 73.05
- TSHA 58.01
- Support Level
- BKSY $8.29
- TSHA $1.85
- Resistance Level
- BKSY $9.17
- TSHA $2.73
- Average True Range (ATR)
- BKSY 0.60
- TSHA 0.27
- MACD
- BKSY 0.39
- TSHA 0.04
- Stochastic Oscillator
- BKSY 94.72
- TSHA 58.47
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.